penfluridol has been researched along with Triple Negative Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ashraf-Uz-Zaman, M; Cucullo, L; German, NA; Mikelis, CM; Sajib, MS | 1 |
| Akwii, R; Alvina, K; Ashraf-Uz-Zaman, M; Farshbaf, MJ; German, NA; Kallem, RR; Mikelis, CM; Putnam, W; Sajib, MS; Shahi, S; Trippier, PC; Wang, W; Zhang, R | 1 |
| Gupta, P; Ranjan, A; Srivastava, SK | 1 |
3 other study(ies) available for penfluridol and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity.
Topics: Animals; Antineoplastic Agents; Antipsychotic Agents; Cell Line, Tumor; Cell Survival; Central Nervous System; Disease Models, Animal; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Penfluridol; Protein Binding; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2018 |
Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Design; Female; Humans; Mice, Inbred C57BL; Molecular Docking Simulation; Receptor, Fibroblast Growth Factor, Type 1; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Urea | 2021 |
Penfluridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis.
Topics: Animals; Antipsychotic Agents; Cell Line, Tumor; Female; Humans; Mice; Mice, Inbred BALB C; Penfluridol; Signal Transduction; Triple Negative Breast Neoplasms | 2016 |